Sort
50,496 grants matching “lung cancer”
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
$467,377Alice Berger · Fred Hutchinson Cancer Center · R37 · FY2022 · CA
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
$467,377Alice Berger · Fred Hutchinson Cancer Center · R37 · FY2025 · CA
Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer
$467,377Alice Berger · Fred Hutchinson Cancer Research Center · R37 · FY2021 · CA
Control of lethal prostate cancer with a bispecific av and a5b1 integrin antibody
$467,360Paul Mathew · Tufts Medical Center · R01 · FY2022 · CA
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2021 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2019 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2020 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2018 · DK
Inhibiting Bcl-2-regulated intestinal fibrosis in models of Crohnâs Disease
$467,340Peter D.r. Higgins · University Of Michigan At Ann Arbor · R01 · FY2022 · DK
Discovery and optimization of novel mutant-selective allosteric inhibitors of EGFR T790M
$467,339Michael J Eck · Dana-Farber Cancer Inst · R01 · FY2020 · CA
DNA hypermethylation in lung tumors
$467,261Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2022 · CA
DNA hypermethylation in lung tumors
$467,261Gerd P Pfeifer · Van Andel Research Institute · R01 · FY2023 · CA
Studies of the initiation and progression of small cell lung cancer using cells derived by differentiation from human pluripotent stem cells
$467,075Harold E Varmus · Weill Medical Coll Of Cornell Univ · U01 · FY2022 · CA
Mechanisms by which LSD1 Promotes Neuroendocrine Differentiation and Small Cell Lung Cancer
$467,060Matthew Gilbert Oser · Dana-Farber Cancer Inst · R37 · FY2025 · CA
Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection
$467,030Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2019 · CA
Research Infrastructure Core
$466,815Valerie Odero-Marah · Clark Atlanta University · U54 · FY2021 · MD
Regulatory roles of variable mechanical stimuli in cell function
$466,733Bela Suki · Boston University (Charles River Campus) · R01 · FY2011 · HL
Project 1: Murine Modeling of Tumor-Mediated Immunosuppression
$466,711Edgar G. Engleman · Stanford University · U54 · FY2019 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2020 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2021 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2017 · CA
Role of Gi/o-GPCR signaling in breast cancer progression
$466,693Songhai Chen · University Of Iowa · R01 · FY2018 · CA
Novel DNA damage response therapeutics targeting replication protein A
$466,687John J Turchi · Indiana University Indianapolis · R01 · FY2024 · CA
Administrative, biospecimen and biostatistical core
$466,651Robert Jenq · Beckman Research Institute/City Of Hope · P01 · FY2025 · HL
miRNA Expression Profiling
$466,613David M Brown · Ambion Diagnostics, Inc. · R44 · FY2007 · CA